| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on February 27, 2008
Accepted on May 2, 2008
Department of Diabetes and Endocrinology, Division of Molecule and Structure, Gifu University School of Medicine, Gifu, Japan; Laboratory of Medical Genomics, Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan; Department of Metabolic Disorder, Research Institute, International Medical Center of Japan; Department of Medical Biochemistry Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Division of Molecular Metabolism and Diabetes, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Medicine, Diabetes Center, Tokyo Women's Medical University, Tokyo, Japan; Department of Internal Medicine, Akita University School of Medicine, Akita, Japan; Kansai Electric Power Hospital, Osaka, Japan; Division of Endocrinology and Metabolism Department of Medicine, Shiga University of Medical Science, Shiga, Japan; Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan; Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
* To whom correspondence should be addressed. E-mail: kasuga{at}med.kobe-u.ac.jp.
Background: In Europeans and populations of European origin, several groups have recently identified novel type 2 diabetes susceptibility genes including FTO, SLC30A8, HHEX, CDKAL1, CDKN2B, and IGF2BP2, none of which were in the list of functional candidates.
Objective and Design: The aim of this study was to replicate in a Japanese population previously identified associations of SNPs within ten candidate loci with type 2 diabetes using a relatively large sample size: 1921 subjects with type 2 diabetes and 1622 normal controls.
Results: A total of fifteen SNPs were genotyped. Eight SNPs in five loci were found to be associated with type 2 diabetes: rs3802177 [OR=1.16 (95% CI 1.05-1.27), P=4.5 x 10-3] in SLC30A8, rs1111875 [OR=1.27 (95% CI 1.14-1.40), P =1.4 x 10-5] and rs7923837 [OR=1.27 (95% CI 1.13-1.43), P =1.0 x 10-4] in HHEX, rs10811661 [OR=1.27 (95% CI 1.15-1.40), P =1.9 x 10-6] in CDKN2B, rs4402960 [OR=1.23 (95% CI 1.11-1.36), P =8.1 x 10-5] and rs1470579 [OR=1.18 (95% CI 1.07-1.31), P =8.3 x 10-4] in IGF2BP2, and rs7754840 [OR=1.28 (95% CI 1.17-1.41), P =4.5 x 10-7] and rs7756992 [OR=1.27 (95% CI 1.15-1.40), P =9.8 x 10-7] in CDKAL1. The first and second strongest associations were found at variants in CDKAL1 and CDKN2B, both of which are involved in regenerative capacity of pancreatic
-cells.
Conclusions: Some of these variants represent common type 2 diabetes-susceptibility genes in both Japanese and Europeans.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |